While evidence supports the benefits of medications for the treatment of chronic insomnia, there is ongoing debate regarding their appropriate duration of use. A panel of sleep experts …
JM Cloos, CYS Lim Cow… - International Journal of …, 2021 - Wiley Online Library
Objectives A clear definition of what we understand of high‐dose misuse or of a 'markedly increased dose'(as stated by the DSM‐5) is important and past definitions may be …
Objective Mild cognitive impairment (MCI) is associated with increased memory problems although the ability to complete daily life activities remains relatively intact. This study …
EG Teverovsky, A Gildengers, X Ran… - International …, 2024 - cambridge.org
Objectives: Older adults commonly take benzodiazepines (BZDs) that may have long-term adverse cognitive effects. We investigated whether BZD use was related to developing mild …
Benzodiazepines and carbamazepine are mental disorder treatment-related contaminants of emerging concern (CECs) routinely detected in water bodies. Electrochemical oxidation …
K Inada, M Enomoto, K Yamato, K Mishima - Drugs-real world outcomes, 2021 - Springer
Background Prolonged treatment of insomnia using benzodiazepine (BZD) receptor agonists, including BZD and non-BZD hypnotic drugs, can cause drug dependence …
Objective To measure the incidence of long-term benzodiazepine receptor agonist (BZRA) use among individuals with anxiety, mood and/or sleep disorders. To identify factors …
M Enomoto, S Kitamura, H Tachimori… - General hospital …, 2020 - Elsevier
Objective Patients with chronic insomnia are prone to long-term use of hypnotics. Reported risk factors include aging, female sex, and comorbid psychiatric disorders. However, most …
K Isomura, X Wang, Z Chang, C Hellner… - European Journal of …, 2023 - Springer
Purpose Despite being discouraged by guidelines, long-term use of benzodiazepines and related Z-drugs (BZDR) remains frequent in the real-world. An improved understanding of …